Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Metagenomi, Inc. | Director | Common Stock | 1.9M | $5.46M | $2.88 | Feb 13, 2024 | By Humboldt Fund I, LP |
Metagenomi, Inc. | Director | Common Stock | 402K | $1.16M | $2.88 | Feb 13, 2024 | By Praxis Biotech LLC |
Metagenomi, Inc. | Director | Common Stockc | 770K | Feb 13, 2024 | Direct | ||
Metagenomi, Inc. | Director | Stock Option (Right to Buy) | 78.6K | Apr 1, 2024 | Direct | ||
Metagenomi, Inc. | Director | Series A-2 Preferred Stock | 0 | Feb 13, 2024 | Direct | ||
Metagenomi, Inc. | Director | Series A-3 Preferred Stock | 0 | Feb 13, 2024 | Direct | ||
Metagenomi, Inc. | Director | Series A-4 Preferred Stock | 0 | Feb 13, 2024 | By Humboldt Fund I, LP | ||
Metagenomi, Inc. | Director | Series A-4 Preferred Stock | 0 | Feb 13, 2024 | Direct | ||
Metagenomi, Inc. | Director | Series B-1 Preferred Stock | 0 | Feb 13, 2024 | By Humboldt Fund I, LP | ||
Metagenomi, Inc. | Director | Series B Preferred Stock | 0 | Feb 13, 2024 | By Humboldt Fund I, LP |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MGX | Metagenomi, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Director |
MGX | Metagenomi, Inc. | Feb 13, 2024 | 8 | $0 | 4 | Feb 14, 2024 | Director |
MGX | Metagenomi Technologies, LLC | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Director |